Thursday, November 11, 2021 7:40:46 AM
Recent VRPX News
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 07/15/2024 10:40:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/15/2024 12:00:17 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 07/12/2024 08:00:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/10/2024 08:10:52 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 07/10/2024 08:09:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/10/2024 04:48:25 PM
- Virpax Announces Positive Results of Swine Model Pilot Study for Probudur™ • Business Wire • 07/10/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/09/2024 08:02:40 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 07/09/2024 08:00:39 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 07/08/2024 08:32:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/08/2024 11:30:21 AM
- Virpax Pharmaceuticals Secures $2.5 Million Loan Financing and an Agreement with an Institutional Investor to Negotiate Additional Funding • Business Wire • 07/08/2024 11:30:00 AM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/12/2024 09:09:59 PM
- Virpax® Pharmaceuticals to Present at 2024 BIO International Convention • Business Wire • 05/29/2024 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 08:05:48 PM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 05/16/2024 08:00:51 PM
- Virpax Announces Pricing of $2.25 Million Public Offering • Business Wire • 05/15/2024 12:00:00 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 05/13/2024 09:30:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2024 08:20:37 PM
- Virpax Pharmaceuticals Reports 2024 First Quarter Results and Recent Developments • Business Wire • 05/13/2024 08:10:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2024 08:02:37 PM
- Virpax Announces Results of Maximum Tolerated Dose Study for Probudur™ • Business Wire • 04/30/2024 11:30:00 AM
- Virpax Pharmaceuticals Reports 2023 Year-End Results • Business Wire • 03/26/2024 11:30:00 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM